Search

Background In the United States (US), 44% of people with human immunodeficiency virus (PWH) live in the Southeastern census region; many PWH remain undiagnosed. Novel strategies to inform testing outreach in rural states with dispersed HIV epidemics are needed. Methods Alabama state public health HIV testing surveillance data from 2013 to 2017 were used to estimate time from infection to HIV diagnosis using CD4 T-cell depletion modeling, mapped to county. Diagnostic HIV tests performed during 2013–2021 by commercial testing entities were used to estimate HIV tests per 100 000 adults (aged 15–65 years), mapped to client ZIP Code Tabulation Area (ZCTA). We then defined testing "cold spots": those with <10% adults tested plus either (1) within or bordering 1 of the 13 counties with HIV prevalence >400 cases per 100 000 population or (2) within a county with average time to diagnosis greater than the state average to inform testing outreach. Results Time to HIV diagnosis was a median of 3.7 (interquartile range [IQR], 0–9.2) years across Alabama, with a range of 0.06–12.25 years. Approximately 63% of counties (n = 42) had a longer time to diagnosis compared to national US estimates. Six hundred forty-three ZCTAs tested 17.3% (IQR, 10.3%–25.0%) of the adult population from 2013 to 2017. To prioritize areas for testing outreach, we generated maps to describe 47 areas of HIV-testing cold spots at the ZCTA level. Conclusions Combining public health surveillance with commercial testing data provides a more nuanced understanding of HIV testing gaps in a state with a rural HIV epidemic and identifies areas to prioritize for testing outreach. [ABSTRACT FROM AUTHOR]

This study explored the intersecting forms of stigma experienced by HIV-serodifferent couples with unmet reproductive goals in rural Uganda. The parent mixed-methods study, which included 131 HIV-exposed women with plans for pregnancy, offered comprehensive HIV prevention counselling and care over a nine-month period. In-depth interviews were conducted with 37 women and seven male partners to explore care experiences and the use of safer conception strategies. This secondary analysis explored how challenges conceiving informed pregnancy plans and HIV prevention behaviours. The following themes were developed (1) partnership conflicts arise from HIV- and infertility-related forms of stigma, contributing to gender-based violence, partnership dissolution and the pursuit of new partners; (2) cultural and gender norms pressure men and women to conceive and maintain partnerships, which is complicated by the stigma directed towards serodifferent couples; (3) frustration with low partner participation in safer conception strategies led to the decreased use of these methods of HIV prevention; (4) health care provider support promotes continued hope of conception and helps overcome stigma. In HIV-affected partnerships, these intersecting forms of stigma may impact HIV prevention. Seeking to fulfil their reproductive needs, partners may increase HIV transmission opportunities as they engage in condomless sex with additional partners and decrease adherence to prevention strategies. Future research programmes should consider the integration of fertility counselling with reproductive and sexual health care. [ABSTRACT FROM AUTHOR]

Background: Many men with HIV (MWH) want to have children. HIV viral suppression minimizes sexual HIV transmission risks while allowing for conception and optimization of the health of men, their partners, and their infants. Objective: This study developed and evaluated the feasibility and acceptability of an intervention to promote serostatus disclosure, antiretroviral therapy (ART) uptake and adherence, and viral suppression among MWH who want to have children in South Africa. Methods: We developed a safer conception intervention (Sinikithemba Kwabesilisa or We give hope to men) to promote viral suppression via ART uptake and adherence, HIV serostatus disclosure, and other safer conception strategies for MWH in South Africa. Through 3 counseling and 2 booster sessions over 12 weeks, we offered education on safer conception strategies and aided participants in developing a safer conception plan. We recruited MWH (HIV diagnosis known for >1 month), not yet accessing ART or accessing ART for <3 months, in a stable partnership with an HIV-negative or unknown-serostatus woman, and wanting to have a child in the following year. We conducted an open pilot study to evaluate acceptability based on patient participation and exit interviews and feasibility based on recruitment and retention. In-depth exit interviews were conducted with men to explore intervention acceptability. Questionnaires collected at baseline and exit assessed disclosure outcomes; CD4 and HIV-RNA data were used to evaluate preliminary impacts on clinical outcomes of interest. Results: Among 31 eligible men, 16 (52%) enrolled in the study with a median age of 29 (range 27-44) years and a median time-since-diagnosis of 7 months (range 1 month to 9 years). All identified as Black South African, with 56% (9/16) reporting secondary school completion and 44% (7/16) reporting full-time employment. Approximately 44% (7/16) of participants reported an HIV-negative (vs unknown-serostatus) partner. Approximately 88% (14/16) of men completed the 3 primary counseling sessions. In 11 exit interviews, men reported personal satisfaction with session content and structure while also suggesting that they would refer their peers to the program. They also described the perceived effectiveness of the intervention and self-efficacy to benefit. Although significance testing was not conducted, 81% (13/16) of men were taking ART at the exit, and 100% (13/13) of those on ART were virally suppressed at 12 weeks. Of the 16 men, 12 (75%) reported disclosure to pregnancy partners. Conclusions: These preliminary data suggest that safer conception care is acceptable to men and has the potential to reduce HIV incidence among women and their children while supporting men’s health. Approximately half of the men who met the screening eligibility criteria were enrolled. Accordingly, refinement to optimize uptake is needed. Providing safer conception care and peer support at the community level may help reach men. [ABSTRACT FROM AUTHOR]

Background: HIV disproportionately affects Black women in the Southern U.S., yet utilization of HIV pre-exposure prophylaxis (PrEP) for HIV prevention among cis-gender women remains low, with particularly inequitable access among Black women. Gynecology clinics provide an ideal location for PrEP services, alongside already-available sexual, reproductive, and primary health care services for many cis-gender women. Methods: We conducted qualitative in-depth interviews with key informants at a gynecology continuity clinic serving under- and uninsured women in Alabama to evaluate individual-, setting-, and process-level determinants of PrEP care provision. The clinic serves approximately 3,000 women yearly, 64% of whom are Black women. Interview guides utilized the Information-Motivation- Behavioral Skills Model to explore barriers and facilitators affecting PrEP implementation, including provider knowledge about PrEP, motivations to integrate PrEP into routine gynecologic care, and skills needed to deliver PrEP care. A codebook was developed from interview transcripts, and further detailed inductive codes were developed by the study team. Interviews were coded by two team members to identify emergent themes. Results: Seven key informants participated in interviews, with a mean age of 33 years and positions including, among others, attending and trainee physicians. The following themes emerged: (1) Gynecology providers discuss sexual health with their patients, but rarely discuss PrEP; (2) Providers support an interdisciplinary team approach to PrEP implementation, inclusive of physicians, advanced practice providers, nurses, medical assistants, and office staff; (3) Longitudinal and iterative provider education on PrEP is an important motivator for discussions about PrEP with patients; (4) Providers need communication and cultural competency skills to build trust and rapport with patients, which ameliorate community stigma around discussions about HIV prevention. Conclusion: PrEP implementation in gynecology clinics can improve access to HIV prevention for cisgender Black women in Alabama. Increasing provider knowledge about PrEP provision and care boosts provider confidence discussing PrEP with patients. Utilizing an interdisciplinary approach across clinic staff may normalize PrEP discussions, allowing patients time to ask questions at many intervals with providers trained on providing culturally appropriate care. These findings will inform development of implementation strategies to integrate PrEP care into routine gynecologic care in the American South. [ABSTRACT FROM AUTHOR]